05/06/2026 | News release | Distributed by Public on 05/06/2026 09:49
APPLICATION DEADLINE: May 15, 2026
Nucleate, in collaboration with Eli Lilly & Company, has launched the 2026 Grand Challenge to spotlight a new generation of therapeutics and technologies aimed at improving how individuals age.
The program is open to early-stage biotech founders and researchers worldwide. Teams tackling unique challenges in mobility & frailty, cognitive & sensory health, immune resilience, and regenerative medicine are invited to apply. This program is designed to accelerate your impact by connecting you with funding, mentorship, and resources to drive your scientific innovation toward real-world impact.
LEARN MORE | APPLY NOW | UPCOMING INFO SESSION (May 12)